Related Experiment Video
Updated: May 9, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
Understanding 'embedded pharmaceuticalisation': A case study of sleeping medication use in later life
Georgia Smith1, Hannah Farrimond1
1University of Exeter, UK.
Health (London, England : 1997)
|February 12, 2026
Summary
Long-term sleeping medication use persists in older adults due to a deep emotional need for sleep, overriding concerns. This
Area of Science:
- Sociology
- Gerontology
- Pharmaceutical Studies
Background:
- Sleeping medication use in older adults is associated with adverse effects like falls and cognitive decline.
- Despite guidelines for reduced prescribing, long-term use remains common among seniors.
- Sociological studies reveal ambivalence and unease regarding sleep aid dependency in later life.
Purpose of the Study:
- To explore the reasons behind the persistent long-term use of sleeping medications in older adults.
- To understand how sleeping medication use becomes embedded in the lives of elderly individuals.
- To investigate the interplay between emotional needs, perceived necessity, and continued reliance on sleep aids.
Main Methods:
- Qualitative study involving interviews and diaries with 38 UK adults aged 65 and older.
- Average duration of sleeping medication use among participants was 17 years.
- Analysis focused on understanding the persistence of use despite expressed concerns.
Main Results:
- Participants expressed moral concerns but prioritized a profound emotional need for sleep.
- Sleeping medication was viewed as the sole effective remedy, leading to 'embedded pharmaceuticalisation'.
- Users employed active (sourcing, stockpiling) and passive (avoiding reviews) strategies to sustain use, driven by necessity and habit.
Conclusions:
- Long-term sleeping medication use in older adults is sustained by a process of 'embedded pharmaceuticalisation', where medication becomes integral to emotional life and identity.
- The perceived necessity and emotional reliance on sleep aids outweigh expressed desires to reduce or avoid them.
- Understanding these trajectories is crucial for addressing the persistence of medication use beyond initial prescribing.
Related Concept Videos
Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

